Harrow Health Inc (HROW)vsViatris Inc (VTRS)
HROW
Harrow Health Inc
$29.37
-3.64%
HEALTHCARE · Cap: $1.10B
VTRS
Viatris Inc
$20.67
-1.85%
HEALTHCARE · Cap: $23.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Viatris Inc generates 4756% more annual revenue ($14.73B vs $303.25M). VTRS leads profitability with a -4.1% profit margin vs -9.4%. VTRS earns a higher WallStSmart Score of 40/100 (D).
HROW
Hold40
out of 100
Grade: F
VTRS
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HROW.
Margin of Safety
-81.4%
Fair Value
$8.89
Current Price
$20.67
$11.78 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 38.6% year-over-year
Earnings expanding 810.0% YoY
Reasonable price relative to book value
Areas to Watch
Smaller company, higher risk/reward
Trading at 38.1x book value
ROE of -35.4% — below average capital efficiency
Negative free cash flow — burning cash
Expensive relative to growth rate
ROE of -2.9% — below average capital efficiency
Revenue declined 0.3%
Earnings declined 70.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : HROW
The strongest argument for HROW centers on Revenue Growth, EPS Growth. Revenue growth of 38.6% demonstrates continued momentum.
Bull Case : VTRS
The strongest argument for VTRS centers on Price/Book.
Bear Case : HROW
The primary concerns for HROW are Market Cap, Price/Book, Return on Equity. Debt-to-equity of 19.79 is elevated, increasing financial risk.
Bear Case : VTRS
The primary concerns for VTRS are PEG Ratio, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
HROW profiles as a hypergrowth stock while VTRS is a turnaround play — different risk/reward profiles.
VTRS carries more volatility with a beta of 0.87 — expect wider price swings.
HROW is growing revenue faster at 38.6% — sustainability is the question.
VTRS generates stronger free cash flow (329M), providing more financial flexibility.
Bottom Line
HROW scores higher overall (40/100 vs 40/100) and 38.6% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Harrow Health Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
Viatris Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
Visit Website →Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?